Search research articles
Contact Us
Filters
Showing results (61-70 of 103) with videos related to
Page
of 11
Sort By:
Oncotarget
|
November 2, 2017
Loss of cadherin related family member 5 (CDHR5) expression in clear cell renal cell carcinoma is a prognostic marker of disease progression
Felix Marius Bläsius, Sebastian Meller, Carsten Stephan, et al.
Nutrients
|
February 11, 2023
The Genetic Background Is Shaping Cecal Enlargement in the Absence of Intestinal Microbiota
Silvia Bolsega, Anna Smoczek, Chen Meng, et al.
Digital Health
|
August 12, 2024
Evaluating ChatGPT responses to frequently asked patient questions regarding periprosthetic joint infection after total hip and knee arthroplasty
Xiaojun Hu, Marcel Niemann, Arne Kienzle, et al.
Plos One
|
January 4, 2014
Diagnostic and prognostic value of SHOX2 and SEPT9 DNA methylation and cytology in benign, paramalignant and malignant pleural effusions
Dimo Dietrich, Maria Jung, Svenja Puetzer, et al.
Bone & Joint Open
|
June 5, 2024
MicroRNA expression analysis in peripheral blood and soft-tissue of patients with periprosthetic hip infection
Alp Paksoy, Sebastian Meller, Florian Schwotzer, et al.
Frontiers in Veterinary Science
|
July 5, 2022
Neurostimulation as a Method of Treatment and a Preventive Measure in Canine Drug-Resistant Epilepsy: Current State and Future Prospects
Marta Nowakowska, Muammer Üçal, Marios Charalambous, et al.
Epigenetics
|
October 1, 2016
CDO1 promoter methylation is associated with gene silencing and is a prognostic biomarker for biochemical recurrence-free survival in prostate cancer patients
Sebastian Meller, Lisa Zipfel, Heidrun Gevensleben, et al.
Frontiers in Neuroscience
|
February 15, 2024
Fecal supernatants from dogs with idiopathic epilepsy activate enteric neurons
Kristin Elfers, Antja Watanangura, Pascal Hoffmann, et al.
The Journal of Molecular Diagnostics : JMD
|
December 13, 2016
PITX2 DNA Methylation as Biomarker for Individualized Risk Assessment of Prostate Cancer in Core Biopsies
Barbara Uhl, Heidrun Gevensleben, Yuri Tolkach, et al.
Oncotarget
|
July 28, 2016
CXCL12 promoter methylation and PD-L1 expression as prognostic biomarkers in prostate cancer patients
Diane Goltz, Emily Eva Holmes, Heidrun Gevensleben, et al.
Page
of 11
Search research articles
Search
Showing results (61-70 of 103) with videos related to
Sort By:
Page
of 11
Oncotarget
|
November 2, 2017
Loss of cadherin related family member 5 (CDHR5) expression in clear cell renal cell carcinoma is a prognostic marker of disease progression
Felix Marius Bläsius, Sebastian Meller, Carsten Stephan, et al.
Nutrients
|
February 11, 2023
The Genetic Background Is Shaping Cecal Enlargement in the Absence of Intestinal Microbiota
Silvia Bolsega, Anna Smoczek, Chen Meng, et al.
Digital Health
|
August 12, 2024
Evaluating ChatGPT responses to frequently asked patient questions regarding periprosthetic joint infection after total hip and knee arthroplasty
Xiaojun Hu, Marcel Niemann, Arne Kienzle, et al.
Plos One
|
January 4, 2014
Diagnostic and prognostic value of SHOX2 and SEPT9 DNA methylation and cytology in benign, paramalignant and malignant pleural effusions
Dimo Dietrich, Maria Jung, Svenja Puetzer, et al.
Bone & Joint Open
|
June 5, 2024
MicroRNA expression analysis in peripheral blood and soft-tissue of patients with periprosthetic hip infection
Alp Paksoy, Sebastian Meller, Florian Schwotzer, et al.
Frontiers in Veterinary Science
|
July 5, 2022
Neurostimulation as a Method of Treatment and a Preventive Measure in Canine Drug-Resistant Epilepsy: Current State and Future Prospects
Marta Nowakowska, Muammer Üçal, Marios Charalambous, et al.
Epigenetics
|
October 1, 2016
CDO1 promoter methylation is associated with gene silencing and is a prognostic biomarker for biochemical recurrence-free survival in prostate cancer patients
Sebastian Meller, Lisa Zipfel, Heidrun Gevensleben, et al.
Frontiers in Neuroscience
|
February 15, 2024
Fecal supernatants from dogs with idiopathic epilepsy activate enteric neurons
Kristin Elfers, Antja Watanangura, Pascal Hoffmann, et al.
The Journal of Molecular Diagnostics : JMD
|
December 13, 2016
PITX2 DNA Methylation as Biomarker for Individualized Risk Assessment of Prostate Cancer in Core Biopsies
Barbara Uhl, Heidrun Gevensleben, Yuri Tolkach, et al.
Oncotarget
|
July 28, 2016
CXCL12 promoter methylation and PD-L1 expression as prognostic biomarkers in prostate cancer patients
Diane Goltz, Emily Eva Holmes, Heidrun Gevensleben, et al.
Page
of 11